Lung Cancer | Oncology Today with Dr Neil Love: The Role of Immunotherapy Combination Approaches in the Management of Metastatic Non-Small Cell Lung Cancer

published 7 months ago by Dr Neil Love

Featuring an interview with Dr Stephen V Liu on the following topics: Management of metastatic non-small cell lung cancer (NSCLC) without an actionable gene mutation (0:00) Case: A man in his late 60s with recurrent NSCLC, high tumor mutational burden and high PD-L1 expression receives nivolumab and ipilimumab with chemotherapy on the CheckMate 9LA study (18:44) Case: A man in his early 80s with metastatic non-small cell lung cancer (NSCLC), PD-L1 expression of 15% and no actionable alterations refuses chemotherapy and receives nivolumab with ipilimumab (22:09) Case: A man in his mid-60s with NSCLC, asymptomatic brain metastases and undetectable PD-L1 expression receives off-label nivolumab with ipilimumab (24:45) CME information and select publications

more episodes from Research To Practice | Oncology Videos